Other
Prophylaxis
1
Pipeline Programs↗
39
Active Trials↗
17
Companies Involved↗
Prophylaxis is an early-stage landscape with 1 program across 17 companies. The most active players are Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Acacia Pharma Ltd, Bayer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 11
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
232
clinical trials
Completed134 · 58%
Unknown status29 · 13%
Recruiting25 · 11%
Terminated17 · 7%
Withdrawn13 · 6%
Not yet recruiting6 · 3%
Other8 · 3%
Clinical Trials
Trial Activity
232 trials
Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT
Recruiting·—·N/A·NCT06441669·60 enrolled
Doxycycline Intervention for Bacterial STI ChemoprOphylaxis (DISCO)
Recruiting·—·N/A·NCT04762134·560 enrolled
The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir
Recruiting·Evandro Chagas National Institute of Infectious Disease·Phase 3·NCT05515770·1,200 enrolled
Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding
Recruiting·—·Phase 2/3·NCT04499898·306 enrolled
Page 1 of 16
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)